glucagon has been researched along with cyproheptadine in 16 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (cyproheptadine) | Trials (cyproheptadine) | Recent Studies (post-2010) (cyproheptadine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 2,297 | 262 | 201 |
| Protein | Taxonomy | glucagon (IC50) | cyproheptadine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0024 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.564 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.035 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.016 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0031 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0038 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.283 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.016 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.164 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0031 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.038 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.275 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.122 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.046 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.158 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.564 | |
| Histamine H2 receptor | Homo sapiens (human) | 0.198 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.107 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.001 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0024 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.122 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0031 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0037 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.048 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0094 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.281 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.14 | |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itaya, K; Itoh, M | 1 |
| Calle, C; Hedo, JA; Marco, J; Martinell, J; Villanueva, ML | 1 |
| Fischer, LJ; Rickert, DE | 1 |
| Bryce, GF; Jacoby, JH | 2 |
| Blondel, B; Halban, PA; Niesor, E; Renold, AE; Wollheim, CB | 1 |
| Hainer, V; Krejcík, L; Stárka, L; Urbánek, J | 1 |
| Balestreri, R; Barban, G; Bertolini, S; Castello, C; Fattorini, A; Fontana, L; Schiaffino, GL | 1 |
| Beckmann, J; Hasselblatt, A; Holze, S; Joost, HG; Lenzen, S; Poser, W | 1 |
| Bionda, S; Delitala, G; Devilla, L; Franca, V | 1 |
| Goto, M; Inoue, H; Inoue, O; Seyama, Y; Yamashita, S; Yumioka, E | 1 |
| Chow, SA; Fischer, LJ | 1 |
| Davis, RL; Eaton, RP; Girard, DL | 1 |
| Barseghian, G; Hwang, D; Josefsberg, Z; Lev-Ran, A; Tomkinson, C | 1 |
| Hainer, V; Krejcik, L; Malec, B; Urbánek, J | 1 |
| Cabezas-Cerrato, J; Casanueva, F; Fernández-Cruz, A; Muñóz, J; Peñalva, A; Villanueva, L | 1 |
16 other study(ies) available for glucagon and cyproheptadine
| Article | Year |
|---|---|
Effect of 5-hydroxytryptamine on blood glucose and cyclic AMP in the rat.
Topics: Adrenal Medulla; Animals; Antibodies; Blood Glucose; Cyclic AMP; Cyproheptadine; Epinephrine; Glucagon; Hexamethonium Compounds; Injections, Intraperitoneal; Male; Propranolol; Rats; Serotonin | 1979 |
Potentiation of glucagon secretion by serotonin antagonists in man.
Topics: Arginine; Cyproheptadine; Fenclonine; Glucagon; Humans; Hypoglycemia; Insulin; Methysergide; Serotonin; Serotonin Antagonists | 1976 |
Cyproheptadine and beta cell function in the rat: insulin secretion from pancreas segments in vitro.
Topics: Administration, Oral; Animals; Bucladesine; Cyproheptadine; Dose-Response Relationship, Drug; Glucagon; Glucose; In Vitro Techniques; Injections, Intraperitoneal; Insulin; Insulin Secretion; Islets of Langerhans; Leucine; Male; Rats; Tolbutamide | 1975 |
A comparative study of several serotonin receptor antagonists on basal and stimulus induced release of insulin and glucagon in the intact rat.
Topics: Animals; Arginine; Cinanserin; Cyproheptadine; Glucagon; Glucose; Insulin; Islets of Langerhans; Male; Metergoline; Methysergide; Rats; Receptors, Serotonin | 1978 |
Perturbation of hormone storage and release induced by cyproheptadine in rat pancreatic islets in vitro.
Topics: Animals; Cyproheptadine; Glucagon; Glucose; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Proteins; Rats | 1979 |
Paradoxical short-term effects of cyproheptadine on insulin and glucagon release in the rat.
Topics: Adrenal Medulla; Animals; Blood Glucose; Cyproheptadine; Glucagon; Insulin; Male; Phentolamine; Rats; Time Factors | 1979 |
Glucagon-induced fall of serum cortisol levels: effect of cyproheptadine pretreatment.
Topics: Adult; Blood Glucose; Cyproheptadine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hydrocortisone; Middle Aged | 1979 |
[Effect of cyproheptadine treatment on human glucagon-induced insulin secretion].
Topics: Blood Glucose; Cyproheptadine; Glucagon; Humans; Insulin; Insulin Secretion; Male | 1977 |
Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran).
Topics: Animals; Cyproheptadine; Glucagon; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Rats | 1976 |
Suppression of human growth hormone secretion by cyproheptadine.
Topics: Child; Cyproheptadine; Female; Glucagon; Glucose; Growth Hormone; Humans; Levodopa; Male; Reference Values | 1977 |
[Comparative effects of traditional Chinese medicines (dai-saiko-to, hatimi-zio-gan and byakko-ka-ninzin-to) on experimental diabetes and hyperlipidemia].
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Cyproheptadine; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Glucagon; Hyperlipidemias; Insulin; Male; Rats; Rats, Inbred Strains | 1989 |
Susceptibility of fetal rat endocrine pancreas to the diabetogenic action of cyproheptadine.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Cyproheptadine; Female; Fetus; Glucagon; Insulin; Maternal-Fetal Exchange; Organ Size; Pancreas; Pregnancy; Radioimmunoassay; Rats; Rats, Inbred Strains | 1986 |
Hormonal basis for the Dumping syndrome.
Topics: Bradykinin; Cyproheptadine; Dumping Syndrome; Glucagon; Glucose Tolerance Test; Humans; Intestinal Mucosa; Male; Middle Aged; Serotonin | 1974 |
Fenfluramine inhibits insulin secretion and potentiates glucagon release by the perfused rat pancreas.
Topics: Animals; Cyproheptadine; Fenclonine; Fenfluramine; Glucagon; Glucose; Insulin; Insulin Secretion; Male; Pancreas; Phentolamine; Rats; Rats, Inbred Strains; Serotonin | 1983 |
The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon.
Topics: Adult; Cyproheptadine; Dopamine; Female; Glucagon; Growth Hormone; Humans; Injections, Intramuscular; Male; Middle Aged; Pimozide; Serotonin; Thyrotropin-Releasing Hormone | 1981 |
[Lack of action of phentolamine, fenfluramine and cyproheptadine on the growth hormone secretion induced by glucagon (author's transl)].
Topics: Adolescent; Adult; Cyproheptadine; Female; Fenfluramine; Glucagon; Growth Inhibitors; Growth Substances; Humans; Male; Phentolamine; Pituitary Gland | 1980 |